Template:Hyperlipoproteinemia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 39: | Line 39: | ||
! | ! | ||
[[Hyperlipoproteinemia#Classification|Classification]] | [[Hyperlipoproteinemia#Classification|Classification]] | ||
:'''Type I - [[Familial hyperchylomicronemia]]''' | :'''Type I - [[Familial hyperchylomicronemia]]''' | ||
:'''Type II''' | :'''Type II''' | ||
::'''Type IIA - [[Familial hypercholesterolemia]]''' | ::'''Type IIA - [[Familial hypercholesterolemia]]''' | ||
::'''Type IIB - [[Familial combined hyperlipidemia]]''' | ::'''Type IIB - [[Familial combined hyperlipidemia]]''' | ||
:'''Type III - [[Dysbetalipoproteinemia]]''' | :'''Type III - [[Dysbetalipoproteinemia]]''' | ||
:'''Type IV - [[Primary hypertriglyceridemia]]''' | |||
:'''Type V - [[Mixed hyperlipoproteinemia]]''' | |||
|- | |- | ||
! | ! | ||
Line 104: | Line 51: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Hyperlipoproteinemia#Differential Diagnosis|Differential Diagnosis]] | |||
|- | |- | ||
! | ! | ||
Line 110: | Line 57: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Hyperlipoproteinemia#Screening|Screening]] | |||
|- | |- | ||
! | ! |
Revision as of 18:51, 2 March 2017
Hyperlipoproteinemia Microchapters |
|
ACC/AHA Guideline Recommendations |
Intensity of statin therapy in primary and secondary prevention |